Refine by
Sleep Apnea Articles & Analysis
57 news found
Are you restless during sleep at night? Do you often wake up at night due to bad dreams or have difficulty in falling asleep? Are you anxious before you sleep? There are a variety of issues that can hamper proper and restful sleep at night, apart from snoring. According to University of Arizona clinical professor of medicine and dream specialist, Rubin Naiman, PhD, the two key components of good ...
What is Newborn Snoring? Oftentimes, newborns breathe noisily when they sleep. It may be caused due to extra mucus or dryness in their tiny nasal passages. However, if you notice your newborn baby actually snoring on a regular basis, consult with a doctor. If your snoring is causing issues with your partner or his/her snoring is irritating you at night, it is important that you seek timely ...
Snoring is one of the key signs of not just allergies but a variety of ailments including sleep apnea and cardiac issues if it goes undiagnosed. For those unlucky individuals, who suffer with chronic snoring and other sleep-related disorders, their suffering is exacerbated by the many allergens floating through the air, at this time. ...
Brandon Nokes, Professor Atul Malhotra, and other collaborators, is based on a post-hoc analysis of 65 participants with mild obstructive sleep apnea (OSA) who completed sleep testing before and after six weeks of genioglossus (tongue muscle) neuromuscular electrical stimulation (NMES) with eXciteOSA. ...
The data demonstrated that real-world patients in the US prescribed eXciteOSA, the first daytime therapy indicated to treat primary snoring and mild obstructive sleep apnea (OSA), exhibited strong adherence to the treatment by using therapy on over 80% of days over the first six weeks of treatment. ...
This is commonly referred to as “gum surgery.” Sleep Apnea Those who suffer torturous nights due to sleep apnea can seek relief with help from an oral surgeon. ...
Adults between the ages of 18 and 60 years with morbid obesity (BMI of > 40) or severe obesity (BMI of > 35) with at least one complication (diabetes, hypertension, sleep apnea syndrome, joint disorders) People who have already tried to lose weight without success despite receiving specialized medical care for several months (dietary monitoring, physical ...
I am sleeping more deeply and am actually giving my lungs a rest. Peter - Breathing I have used SoeMac for over 3 years, and it has certainly been a great help. ...
BySoeMac
Prior to his time at Quanta, Lipman was Chief Commercial Officer at NightBalance for four years before its acquisition by Philips, where he was responsible for leading the U.S. launch of the Lunoa sleep therapy device. He was also Vice President of marketing and sales at ApniCure, where he deployed and expanded a U.S. sales team to launch a new treatment for obstructive ...
PepsinCheck represents the first at-home reflux testing in the US market and holds the potential to revolutionize the care of individuals with symptoms ranging from heartburn, to chronic cough, and even obstructive sleep apnea.” Professor Peter Dettmar, director of RD Biomed, said: “We’re thrilled that our salivary pepsin test for diagnosing ...
ByRestech
Citrine’s lead product candidate, Wakix® (pitolisant), is an investigational oral drug in development for the treatment of narcolepsy and obstructive sleep apnea in China. Citrine has initiated an Investigational New Drug (IND) submission for pitolisant in the treatment of narcolepsy and completed the IND submission in the first quarter of 2021. ...
Signifier is the developer of the revolutionary eXciteOSA® medical device for the treatment of sleep disordered breathing, which has now been launched in key markets including the United States of America, Canada, the United Kingdom and Germany. Nearly one billion adults aged 30 to 69 years globally are estimated to suffer from OSA (Obstructive Sleep ...
“Veravas Inc., founded last year, says it's developed a novel technology with the potential to change the way conditions such as Alzheimer's and sleep apnea are diagnosed. If successful, the company, whose chief lab is in Oakdale, could make a splash in the billion-dollar in-vitro diagnostics market. ...
Signifier Medical Technologies LLC, a Boston-based medical technology company, announced today that the Centers for Medicare & Medicaid Services (CMS) established two new Level II Healthcare Common Procedure Coding System (HCPCS) codes to describe eXciteOSA, the first-ever FDA authorized de-novo device for daytime treatment of mild obstructive sleep apnea ...
AcuPebble SA100 is clinically equivalent to cardiorespiratory polygraphy for the automated diagnosis of obstructive sleep apnea (OSA) at home, a paper published in the BMJ Open has revealed. ...
Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)(“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today provided a general corporate update. 2021 Highlights Implanted first U.S. patient in the DREAM IDE pivotal study in ...
Jacksonville, FL– December 16, 2021 -- RCSM, a leader in respiratory and sleep medicine in Florida, and Spire Health, the leading digital healthcare company for respiratory remote patient monitoring (RPM), today announced a partnership to provide a remote monitoring service to respiratory patients in the Jacksonville area. ...
Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that Olivier Taelman, Chief Executive Officer, will participate at the Piper Sandler 33rd Annual Virtual ...
Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)(“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that Loïc Moreau will join Nyxoah as CFO as of January 1, 2022. ...
Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)(“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that Olivier Taelman, Chief Executive Officer, will participate at the Stifel 2021 Virtual Healthcare Conference ...